Electrochemical Behavior of Atorvastatin at Glassy Carbon Electrode and its Direct Determination in Pharmaceutical Preparations by Square Wave and Differential Pulse Voltammetry

被引:10
作者
Yilmaz, B. [1 ]
Kaban, S. [1 ]
机构
[1] Ataturk Univ, Dept Analyt Chem, Fac Pharm, TR-25240 Erzurum, Turkey
关键词
Atorvastatin; cyclic voltammetry; square wave voltammetry; differential pulse voltammetry; glassy carbon electrode; COA REDUCTASE INHIBITOR; BIOLOGICAL-FLUIDS; DOSAGE FORMS; HUMAN PLASMA; HYPERCHOLESTEROLEMIA; OXIDATION; EFFICACY; SAFETY;
D O I
10.4172/pharmaceutical-sciences.1000126
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A simple and rapid electrochemical method for the determination of atorvastatin in pharmaceutical preparations was developed. The anodic peak at 1.07 V obtained in a buffer on glassy carbon electrode was used for analysis. The peak current and peak potential depends on pH, scan rate and initial potential. Decrease of the anodic peak with increasing pH, as well as deviations from linear plots of ip= f(C) and i= kv(1/2) indicate that this peak at higher concentrations is affected by adsorption-desorption phenomena. The calibration curves were linear for atorvastatin at the concentration range of 1-50 mu g/ml or square wave and differential pulse voltammetry methods, respectively. Intra and interday precision values for atorvastatin were less than 3.17, and accuracy (relative error) was better than 1.93%. The mean recovery of atorvastatin was 100.4% for pharmaceutical preparations. Limits of detection were 0.3 mu g/ml and 0.2 mu g/ml for square wave and differential pulse voltammetry, respectively. Developed methods in this study are accurate, precise and can be easily applied to Ator, Cholvast and Lipitor tablets as pharmaceutical preparation.
引用
收藏
页码:360 / 367
页数:8
相关论文
共 24 条
[1]   Voltammetric oxidation and determination of atorvastatin based on the enhancement effect of cetyltrimethyl ammonium bromide at a carbon paste electrode [J].
Abbar, Jyothi C. ;
Nandibewoor, Sharanappa T. .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2013, 106 :158-164
[2]  
Al-Akkam EJ., 2013, INT J PHARM PHARM SC, V5, P211
[3]  
[Anonymous], ELECTROANALYTICAL TE
[4]   Spectrophotometric and TLC-densitometric methods for the simultaneous determination of Ezetimibe and Atorvastatin calcium [J].
Baghdady, Yehia Z. ;
Al-Ghobashy, Medhat A. ;
Abdel-Aleem, Abdel-Aziz E. ;
Weshahy, Soheir A. .
JOURNAL OF ADVANCED RESEARCH, 2013, 4 (01) :51-59
[5]   Efficacy and safety of a new HMG-CoA reductase inhibitor, atorvastatin, in patients with hypertriglyceridemia [J].
BakkerArkema, RG ;
Davidson, MH ;
Goldstein, RJ ;
Davignon, J ;
Isaacsohn, JL ;
Weiss, SR ;
Keilson, LM ;
Brown, WV ;
Miller, VT ;
Shurzinske, LJ ;
Black, DM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 275 (02) :128-133
[6]   A brief review paper of the efficacy and safety of atorvastatin in early clinical trials [J].
BakkerArkema, RG ;
Best, J ;
Fayyad, R ;
Heinonen, TM ;
Marais, AD ;
Nawrocki, JW ;
Black, DM .
ATHEROSCLEROSIS, 1997, 131 (01) :17-23
[7]  
Bernard S., 2012, J APPL PHARM SCI, P150, DOI [10.7324/JAPS.2012.2606, DOI 10.7324/JAPS.2012.2606]
[8]   DETERMINATION OF SOME QUINOLONES IN TABLETS, HUMAN PLASMA AND URINE BY DIFFERENTIAL-PULSE POLAROGRAPHY [J].
CORTI, P ;
CORBINI, G ;
GRATTERI, P ;
FURLANETTO, S ;
PINZAUTI, S .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1994, 111 (01) :83-87
[9]  
Dangre S.C., 2012, Res. J. Pharm. Technol, V5, P641
[10]   Investigation of electrochemical behavior of lipid lowering agent atorvastatin calcium in aqueous media and its determination from pharmaceutical dosage forms and biological fluids using boron-doped diamond and glassy carbon electrodes [J].
Dogan-Topal, Burcu ;
Uslu, Bengi ;
Ozkan, Sibel A. .
COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2007, 10 (07) :571-582